Surgical Studies - Pleural

A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II–III malignant pleural mesothelioma
European Journal of Cardio-Thoracic Surgery, Volume 31, Issue 3, March 2007, Pages 529-534
Marco Lucchi, Antonio Chella, Franca Melfi, Paolo Dini, Marcello Ambrogi, Leonardo Fino, Gabriella Fontanini, Alfredo Mussi

Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma
European Journal of Cardio-Thoracic Surgery, Volume 31, Issue 5, May 2007, Pages 765-770
Antonio E. Martin-Ucar, Apostolos Nakas, John G. Edwards, David A. Waller

Right extrapleural pneumonectomy for malignant mesothelioma via median sternotomy or thoracotomy? Short- and long-term results
European Journal of Cardio-Thoracic Surgery, Volume 31, Issue 5, May 2007, Pages 759-764
John G. Edwards, Antonio E. Martin-Ucar, Duncan J. Stewart, David A. Waller

Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): Feasibility and results
Lung Cancer, Volume 57, Issue 1, July 2007, Pages 89-95
Federico Rea, Giuseppe Marulli, Luigi Bortolotti, Cristiano Breda, Adolfo Gino Favaretto, Lucio Loreggian, Francesco Sartori

Malignant Pleural Mesothelioma: Surgical Management in 285 Patients
The Annals of Thoracic Surgery, Volume 85, Issue 1, January 2008, Pages 257-264
Paul H. Schipper, Francis C. Nichols, Kristine M. Thomse, Claude Deschamps, Stephen D. Cassivi, Mark S. Allen, Peter C. Pairolero

The role of video assisted thoracoscopic pleurectomy/decortication in the therapeutic management of malignant pleural mesothelioma
European Journal of Cardio-Thoracic Surgery, Volume 33, Issue 1, January 2008, Pages 83-88
Apostolos Nakas, Antonio E. Martin Ucar, John G. Edwards, David A. Waller

Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients
The Journal of Thoracic and Cardiovascular Surgery, Volume 135, Issue 3, March 2008, Pages 620-626.e3
Raja M. Flores, Harvey I. Pass, Venkatraman E. Seshan, Joseph Dycoco, Maureen Zakowski, Michele Carbone, Manjit S. Bains, Valerie W. Rusch

Risk Factors for Major Complications After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma
The Annals of Thoracic Surgery, Volume 85, Issue 4, April 2008, Pages 1206-1210
Marc de Perrot, Karen McRae, Masaki Anraku, Keyvan Karkouti, Thomas K. Waddell, Andrew F. Pierre, Gail Darling, Shaf Keshavjee, Michael R. Johnston

Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: The Memorial Sloan-Kettering experience
Lung Cancer, Volume 49, Supplement 1, July 2005, Pages S71-S74
Raja M. Flores

Malignant mesothelioma 2008.
Zervos MD, Bizekis C, Pass HI. Department of Cardiothoracic Surgery, Division of Thoracic Surgery, New York University School of Medicine, New York, USA. zervom01@med.nyu.edu

Current concepts in malignant pleural mesothelioma.
Kaufman AJ, Pass HI. New York University Medical Center, Department of Surgery, 550 First Avenue, NBV-15N1, New York, NY 10016, USA. kaufma01@med.nyu.edu

Newer issues in mesothelioma chemotherapy.
Vogelzang N, Pass HI. Department of Medical Oncology, Nevada Cancer Institute, Las Vegas, Nevada 89135, USA.

Spindle cell tumors of the pleura: differential diagnosis.
Rdzanek M, Fresco R, Pass HI, Carbone M. Thoracic Oncology Program, Cardinal Bernardin Cancer Center, Loyola University, Maywood, Illinois, USA.

Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma: techniques and complications.
Chang MY, Sugarbaker DJ. Division of Thoracic Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA.

Integration of multimodality approaches in the management of malignant pleural mesothelioma.
Martino D, Pass HI. Cardiothoracic Surgery, Wayne State University, Detroit, MI, USA.

Open lung-sparing surgery for malignant pleural mesothelioma: the benefits of a radical approach within multimodality therapy.
Nakas A, Trousse DS, Martin-Ucar AE, Waller DA. Department of Thoracic Surgery, Glenfield Hospital, Groby Road, Leicester LE3 9QA, United Kingdom.

A phase II trial of tetrathiomolybdate after surgery for malignant mesothelioma: final results.
Pass HI, Brewer GJ, Dick R, Carbone M, Merajver S. Department of Cardiothoracic Surgery, New York University School of Medicine, New York, New York 10016, USA. harvey.pass@med.nyu.edu

Diagnosis, staging, and surgical treatment of malignant pleural mesothelioma.
Kent M, Rice D, Flores R. Thoracic Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

A phase II trial of tetrathiomolybdate after surgery for malignant mesothelioma: final results.
Pass HI, Brewer GJ, Dick R, Carbone M, Merajver S. Department of Cardiothoracic Surgery, New York University School of Medicine, New York, New York 10016, USA. harvey.pass@med.nyu.edu

Patterns of local and nodal failure in malignant pleural mesothelioma after extrapleural pneumonectomy and photon-electron radiotherapy.
Gupta V, Krug LM, Laser B, Hudka K, Flores R, Rusch VW, Rosenzweig KE.  Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York City, NY 10065, USA.

Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.
Krug LM, Pass HI, Rusch VW, Kindler HL, Sugarbaker DJ, Rosenzweig KE, Flores R, Friedberg JS, Pisters K, Monberg M, Obasaju CK, Vogelzang NJ. Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA. krugl@mskcc.org

Prognostic features of long-term survivors after surgical management of malignant pleural mesothelioma.
Yan TD, Boyer M, Tin MM, Sim J, Kennedy C, McLean J, Bannon PG, McCaughan BC. Department of Cardiothoracic Surgery, The University of Sydney, Royal Prince Alfred Hospital, Sydney, Australia.

A phase II study of intrapleural immunochemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy, and long-term subcutaneous IL-2 in stage II-III malignant pleural mesothelioma.
Rusch VW.

Surgical therapy of mesothelioma.
Rice D. Department of Thoracic and Cardiovascular Surgery, Unit #445, The University of Texas, M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA, drice@mdanderson.org

 


Believe in a Cure!

Contact us here for immediate expert help and a free copy of the book "100 Questions & Answers About Mesothelioma."

(877) END-MESO
(877) 363-6376